for membrane proteins 6 included only 1,897 coordinate files (604 unique) as of 17 March 2016. Thus, although membrane proteins comprise 20-30% of all proteins in both prokaryotic and eukaryotic organisms 7 , they presently constitute just 1.7% of known atomic-level structures. Although this fraction has increased from 1.0% over the past six years, membrane proteins remain grossly underrepresented. It is less easy to quantify the progress on functional characterization of membrane proteins, but many intrinsically flexible. Typically, purified membrane proteins must be isolated by detergent extraction from cellular lipid bilayers even if they are to be reconstituted into lipidic environments for biochemical characterization or structural analysis; this requirement further complicates structural analysis by crystallography or single-particle cryo-EM.
Progress in atomic-level structure determination
Despite the challenges, impressive progress has been made in the production and analysis of membrane proteins, particularly of late. The triumphs of membrane-protein structure determination are legendary, starting with the structures of bacteriorhodopsin at a helix-resolving resolution in 1975 (ref. 2) and of the photosynthetic reaction center at an atomic level in 1985 (ref. 3) , and later including structures of potassium channels 4 , G-proteincoupled receptor (GPCR) complexes 5 , and hundreds of others. The majority of atomic-level membrane-protein structures have been determined by X-ray crystallography, but some have come from NMR spectroscopy, and cryo-EM has recently become an exciting contributor.
The rate of production of atomic-level structures of membrane proteins is accelerating ( Fig. 1) : 80% of all unique membrane proteins have been reported in the past decade, and over half have come in the past five years. Nevertheless, the structural output on membrane proteins, compared with soluble proteins, remains very low. Whereas the Protein Data Bank (PDB) contained a total of 108,902 active 'protein only' depositions as of 22 March 2016, White's compilation of known structures Proteins in membranes are the portals through which cells, and membrane-delimited organelles within cells, communicate with their external environments, including other cells. Thereby, membrane proteins are crucial components in cellular physiology and biochemistry. Membrane proteins are also involved in processes of disease, and they are the molecular targets of over 40% of all FDA-approved drugs 1 . In membrane proteins, as with soluble proteins, atomic-level structure greatly informs understanding of the biochemistry and physiology of the processes affected by these molecules. Moreover, new principles of structure and connections to function are also developing that are specific to the proteins in lipid bilayers. Further fundamental understanding can be expected to come from more comprehensive structural information on membrane proteins.
Integral membrane proteins present formidable but not insurmountable challenges for biochemical and structural characterization. Problems arise in the recombinant expression of membrane proteins, especially those from eukaryotes; biochemical purification and characterization is more challenging for membrane proteins than for natively soluble proteins, and many membrane proteins are Unique structures (no.)
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Membrane proteins are substantially more challenging than natively soluble proteins as subjects for structural analysis. Thus, membrane proteins are greatly underrepresented in structural databases. Recently, focused consortium efforts and advances in methodology for protein production, crystallographic analysis and cryo-EM analysis have accelerated the pace of atomic-level structure determination of membrane proteins.
structure analysis. SEC can be performed after partial purification based on an affinity tag, typically a polyhistidine fusion peptide; however, through the use of GFP fusions, such candidates can also be identified by fluorescence-detection SEC (FSEC) without purification 11 . Most laboratories have settled on dodecylmaltoside (n-dodecyl b-d-maltoside or DDM) as the detergent of choice for initial solubilization of proteins from membranes, but exchange can then be made into alternative detergents with SEC assessment. Harsher detergents, particularly phosphocholines (Foscholines), may disrupt 3D structure; to address this problem, detergents that better mimic the lipids of membranes have been developed. Notable success has come from maltoseneopentyl glycols (MNGs) 12 . In addition, of particular relevance for cryo-EM, synthetic polymers known as amphipols can be used to displace detergents 13 . Many advances in methods for the handling and analysis of membrane proteins have come from individual laboratories seeking to address difficult problems. However, considerable development has also come from larger initiatives. The National Institutes of Health PSI placed a particular emphasis on this area and had nine centers devoted to membrane proteins in its PSI:Biology phase, including the NYCOMPS 14 project mentioned above (led by myself at NYSBC), the Center for Membrane Protein Structures (led by R. Stroud at the University of California, San Francisco), and the GPCR Network 15 (led by R. Stevens, then at the Scripps Research Institute). In addition, other consortium efforts are in place, including the Structural Genomics Consortium (led by A. Edwards overall, with membraneprotein initiatives led by L. Carpenter at the University of Oxford), the Membrane Protein Structural Dynamics Consortium (led by E. Perozo at the University of Chicago), and the Membrane Protein Laboratory at the Diamond Light Source and Research Complex at Harwell (established by S. Iwata and now coordinated by I. Moraes). These centers have applied robotics and high-throughput methods to the production and analysis of membrane proteins, and they have substantially contributed to the generation of structures.
Advances in crystallographic analysis
Improvements in methods for analyzing membrane-protein structure by X-ray crystallography are also contributing to the growth in structural results. Part of this improvement is strongly connected to advances in expression and purification, notably the ability to test multiple constructs, including insertions of stabilizing fusion domains 16 .
are underrepresented in the PDB at present, it follows that newly solved membrane-protein structures are relatively likely to be novel.
Advances in expression and purification
Many factors are furthering progress in structural analysis of membrane proteins, and improved proficiency in expression and purification of recombinant proteins is certainly a major contributor. Efficient procedures have been developed for screening for expression of membrane proteins in bacterial systems 9 , although their effectiveness for eukaryotic proteins has been limited. Various alternatives are commonly used for the production of recombinant eukaryotic proteins, usually expression from synthetic genes, with a focus on baculovirus-infected insect cells and on cultures of mammalian cells, typically human embryonic kidney cells HEK293. Procedures have also been developed to couple these two aspects, to yield baculovirus transduction of mammalian cells 10 .
Size-exclusion chromatography (SEC) has proven to be highly effective for the identification of suitable constructs and appropriate detergents for solubilization. This method produces high yields in monodisperse elution profiles, thus indicating readiness for complications that affect structural analysis inevitably also affect biochemical studies.
With respect to structural novelty, the situation for membrane proteins also differs from that for soluble proteins. The number of solved structures of soluble proteins has reached a point at which the novelty for families, superfamilies, and folds is approaching saturation 8 . This trend is consistent with the common observations in which proteins with sequences unlike those of any known structures unexpectedly prove to have 3D structures clearly similar to already known structures. This phenomenon has been observed especially frequently in the Protein Structure Initiative (PSI), which focuses on sequence families without prior structural representation 8 . A similarly careful analysis has not been made for membrane proteins; however, albeit anecdotally, the structural genomics experience of the New York Consortium on Membrane Protein Structure (NYCOMPS) indicates that novelty is still commonplace. For 25 structures obtained by NYCOMPS from putatively novel starting points, 16 had new folds, three belonged to new superfamilies, and five were in new structural families at the time of structure solution. Because membrane proteins 28 , and the Slo2.2 potassium channel at 4.5-Å resolution 29 . Compared with many X-ray crystal structures, these current-day cryo-EM resolutions seem modest; however, they certainly suffice for chain tracing at a polyalanine level of analysis, and in many cases side chain definitions allow for full atomic models to be built (Fig. 3b) . What is remarkable, for crystallographers accustomed to experimental maps at comparable nominal resolutions, is the quality of the cryo-EM density that comes from direct imaging without the phase evaluations required for crystallography.
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Prospects
The future looks very bright for structural determination of membrane proteins. Advances such as those described above will remain productive, and continued technological development can be expected. New X-ray sources, such as beamlines at NSLS-II and MAX-IV, with incredible fluxes focused into microbeams, will be available soon. Relevant diffraction methods will enhance the effectiveness of phase evaluations from native membrane proteins, without needing recourse to heavy atoms. The role of cryo-EM in studies of membrane proteins has just begun, and we can expect many future technical advances in specimen preparation, instrumentation and image processing. We can also expect fruitful marriages of higher-resolution structures from crystallography with cryo-EM structures in multiple conformational states and also with computer simulations of conformational transitions. All of these advances should improve our fundamental understanding of membrane biology. Because many membrane proteins of interest have novel structures, de novo phase evaluations are required for crystal-structure determination. As for other biological crystals, anomalous diffraction methods dominate for de novo phasing of membrane proteins; however, anomalous signals are often weak because of poor diffraction overall. This can be true even when selenomethionine substitution provides the phasing element, but it is all the more so for analyses based on native elements such as sulfur. By using high multiplicity from multiple crystals 20 and from varied crystal orientations 21 , as well as lowerthan-usual X-ray energies, excellent progress is being made in solving structures from weak anomalous signals 22 . Because LCP-grown crystals often diffract particularly well, such structures can truly be at an atomic level (Fig. 3a) .
Advances in cryo-EM analysis
Structural analyses by electron microscopy have been important for membrane proteins from the earliest studies 2 , but until recently they had rarely reached an atomic level of resolution and, if so, only from ordered arrays or symmetric viruses. The situation changed dramatically with image corrections associated with direct electron detectors. The advances in detector technology and computational procedures responsible for the newfound excellence of cryo-EM are beyond the scope of this commentary. Recent reviews of cryo-EM methodology have nicely provided the Another part is due to the ready availability of crystallization screens, crystallization robotics and automated visualization of crystallization trials. A special boost for membrane-protein crystallization has come from advances in lipidic cubic phase (LCP) crystallization 17 . LCP-grown crystals form in lipidic bilayers, in which direct lateral protein-protein contacts are formed in a manner often mediated by mono-oleins in the LCP medium, and other contacts are formed between the layers (Fig. 2) . The resulting network has sufficient rigidity to produce exceptional diffraction patterns in many cases. Typically, LCP-grown crystals are quite small (on the order of 10 µm), a property that has been met with parallel developments in fabricated mounts.
Structural analysis of membrane proteins has also benefited from advances in X-ray sources and diffraction methods. Synchrotron beamlines have been developed to deliver X-ray beams matched in size to microcrystals 18 ; microdiffraction beamlines are especially advantageous for use with LCP-grown crystals of membrane proteins. X-ray-free electron laser (XFEL) experiments are notably being used for membrane proteins. An LCP injector has been developed for efficient delivery of LCP-grown microcrystals 19 . Various devices have been developed for the deployment of crystals, including microfluidics, acoustic droplet ejection and grid-based systems. 
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